Inventor · disambiguated record
Vivek K. Vishnudas
Also filed as: VISHNUDAS VIVEK K · VISHNUDAS VIVEK KANNOTH
16 granted patents·20 pending applications·23 citations·filing 2012–2025
89Inventor score
Top patents by PatentIndex Score
36 records- 0186US2024161863A1Interrogatory cell-based assays for identifying drug-induced toxicity markersBERG LLC·Filed 2024·Application pending·0 cites
- 0285US11456054B2Interrogatory cell-based assays and uses thereofBERG LLC·Filed 2018·Granted Sep 27, 2022·2 cites·27 claims
- 0384US11091447B2UBE2K modulators and methods for their useBERG LLC·Filed 2020·Granted Aug 17, 2021·1 cites·8 claims
- 0483US2025123283A1Use of markers including filamin a in the diagnosis and treatment of prostate cancerBERG LLC·Filed 2024·Application pending·0 cites
- 0582US10539566B2Use of markers including filamin A in the diagnosis and treatment of prostate cancerBERG LLC·Filed 2015·Granted Jan 21, 2020·3 cites·23 claims
- 0681US2024062844A1Interrogatory cell-based assays and uses thereofBPGBIO INC·Filed 2023·Application pending·0 cites
- 0780US9886545B2Interrogatory cell-based assays and uses thereofNARAIN NIVEN RAJIN·Filed 2012·Granted Feb 6, 2018·4 cites·22 claims
- 0878US10352947B2Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular diseaseBERG LLC·Filed 2013·Granted Jul 16, 2019·3 cites·14 claims
- 0976US10061887B2Interrogatory cell-based assays and uses thereofVISHNUDAS VIVEK K·Filed 2012·Granted Aug 28, 2018·6 cites·27 claims
- 1073US9533002B2Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-βNARAIN NIVEN RAJIN·Filed 2013·Granted Jan 3, 2017·2 cites·32 claims
- 1172US12303471B2Methods of treatment of temozolomide-resistant glioma using coenzyme Q10BPGBIO INC·Filed 2022·Granted May 20, 2025·0 cites·21 claims
- 1270US11224641B2Enolase 1 (ENO1) compositions and uses thereofBERG LLC·Filed 2018·Granted Jan 18, 2022·0 cites·16 claims
- 1370US2020333344A1Use of markers including filamin a in the diagnosis and treatment of prostate cancerBERG LLC·Filed 2019·Application pending·0 cites
- 1469US10188708B2Enolase 1 (Eno1) compositions and uses thereofBERG LLC·Filed 2015·Granted Jan 29, 2019·1 cites·18 claims
- 1568US11694765B2Interrogatory cell-based assays for identifying drug-induced toxicity markersBERG LLC·Filed 2018·Granted Jul 4, 2023·0 cites·17 claims
- 1668US10188707B2Enolase 1 (Eno1) compositions and uses thereofBERG LLC·Filed 2015·Granted Jan 29, 2019·1 cites·26 claims
- 1763US9797905B2Use of markers in the diagnosis and treatment of prostate cancerBERG LLC·Filed 2016·Granted Oct 24, 2017·0 cites·33 claims
- 1863US2024342138A1Microtubule targeting agentsBPGBIO INC·Filed 2024·Application pending·0 cites
- 1963US2022002255A1Ube2k modulators and methods for their useBERG LLC·Filed 2021·Application pending·0 cites
- 2063US2018031563A1Use of markers in the diagnosis and treatment of prostate cancerBERG LLC·Filed 2017·Application pending·0 cites
- 2162US2025262309A1Proteolysis targeting chimera (protac) compositions using ubiquitin conjugating enzyme ligandsBPGBIO INC·Filed 2025·Application pending·0 cites
- 2260US12437835B2Interrogatory cell-based assays and uses thereofBERG LLC·Filed 2018·Granted Oct 7, 2025·0 cites·43 claims
- 2360US2022096400A1Methods for the treatment of cancer using coenzyme q10 in combination with immune checkpoint modulatorsBERG LLC·Filed 2021·Application pending·0 cites
- 2460US2021169999A1Enolase 1 (eno1) compositions and uses thereofBERG LLC·Filed 2020·Application pending·0 cites
- 2559US2014038838A1Use of markers in the diagnosis and treatment of prostate cancerNARAIN NIVEN RAJIN·Filed 2013·Application pending·0 cites
- 2658US2025017906A1Compounds for use in treating gastric cancerBPGBIO INC·Filed 2022·Application pending·0 cites
- 2757US2022064732A1Methods for treating parkinson's diseaseBERG LLC·Filed 2021·Application pending·0 cites
- 2856US11001891B2Methods for treating Parkinson's diseaseBERG LLC·Filed 2017·Granted May 11, 2021·0 cites·16 claims
- 2954US2017014495A1Enolase 1 (eno1) compositions and uses thereofBERG LLC·Filed 2016·Application pending·0 cites
- 3053US2013315885A1Interogatory cell-based assays for identifying drug-induced toxicity markersNARAIN NIVEN RAJIN·Filed 2012·Application pending·0 cites
- 3152US2018021270A1Methods for the treatment of cancer using coenzyme q10 in combination with immune checkpoint modulatorsBERG LLC·Filed 2017·Application pending·0 cites
- 3247US10023864B2Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-betaBERG LLC·Filed 2015·Granted Jul 17, 2018·0 cites·37 claims
- 3347US2017189350A1Methods of treatment of temozolomide-resistant glioma using coenzyme q10BERG LLC·Filed 2016·Application pending·0 cites
- 3444US2017166891A1Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-betaBERG LLC·Filed 2016·Application pending·0 cites
- 3538US2021252036A1Methods of treating cancer by inhibiting ubiquitin conjugating enzyme e2 k (ube2k)BERG LLC·Filed 2019·Application pending·0 cites
- 3635US2016375113A1Compositions comprising eno1 and their use in methods of treating obesity or overweight and reducing weight gainBERG LLC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →